Australia's largest stock trading and investment forum Australia's #1 stock forum

MYX

Click for more information

1.34%

$4.53 mayne pharma group limited

Analyst price targets after market update, page-42

First 42 Last

Share
Profile

Follow
rogermht

487 Posts.

58

09/08/17

19:28

Post #: 26398833
Share

Originally posted by bug1 ↑

For reference, i found this in the FY16 report;
"Research and development costs
Expenditure on research activities is recognised as an expense in the period in which it is incurred. An intangible asset arising from development expenditure on an internal project is recognised only when the Group can demonstrate the technical feasibility of completing the intangible asset so that it will be available for use or sale, its intention to complete and its ability to use or sell the asset, how the asset will generate future economic benefits, the availability of resources to complete the development and the ability to measure reliably the expenditure attributable to the intangible asset during its development. During the year ended 30 June 2016, 46 development projects met the requirements for capitalisation (2015: 43 development projects)."

Expand

Either way it is an expense account or capital account doesn't matter. It is cash outflow. EBITDA doesn't recognise capitalised expense. One can argue capitalized expense can be cut off. Hence, EBITDA gauge the operating cashflow of a business. But that is far from true given no pharmaceutical firm can cut off R&D.

MYX Price at posting: 74.5¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Tonight's US CPI data could set the tone for November. What are markets expecting?

ARV

Smallcap Artemis Res' jumps 23% on six digit gold grade rockchip find at Titan

OCT

Octava Minerals joins the antimony train with high-grades on the radar at Yallagong, WA

LEX

Lefroy boosts near-surface gold resource by 13% to 439Koz

ARB

Court process clears way for ARB to buy up 4 Wheel Parts business in the US

There are more pages in this discussion • 1 more message in this thread...

First 42 Last

Add MYX (ASX) to my watchlist

(20min delay)
Last $4.53		Change 0.060(1.34%)		Mkt cap ! $385.3M

Open	High	Low	Value	Volume
$4.48	$4.60	$4.48	$470.7K	103.6K

Buyers (Bids)

No.	Vol.	Price($)
1	127	$4.53

Sellers (Offers)

Price($)	Vol.	No.
$4.58	592	1

View Market Depth

No.	Vol.	Price($)
1	127	4.530
1	444	4.520
2	533	4.510
1	444	4.500
1	444	4.490

Price($)	Vol.	No.
4.580	592	1
4.590	592	1
4.600	5780	4
4.630	1000	1
4.640	2479	3

Last trade - 16.10pm 10/10/2024 (20 minute delay)

MYX (ASX) Chart

SPONSORED BY